You are here:

colesevelam (Cholestagel)

Advice

in the absence of a submission from the holder of the marketing authorisation:

colesevelam (Cholestagel®) is not recommended for use within NHS Scotland.

Indication under review: in combination with ezetimibe, with or without a statin, in adult patients with primary hypercholesterolaemia, including patients with familial hypercholesterolaemia.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: colesevelam (Cholestagel)
SMC Drug ID: 690/11
Manufacturer: Genzyme Therapeutics Ltd
Indication: in combination with ezetimibe, with or without a statin, in adult patients with primary hypercholesterolaemia, including patients with familial hypercholesterolaemia.
BNF Category:
Sub Category: 2.12 Lipid-regulating drugs
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 7 February 2011

Back